• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Alexandra Rogers recaps OAB research from SUFU 2022


Abstracts highlight topics such as sacral neuromodulation and percutaneous tibial nerve stimulation.

In this video, Alexandra Rogers, MD, gives an overview of notable overactive bladder research presented at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2022 Winter Meeting in San Diego, California. Rogers is a urologist in Boulder, Colorado.

The following abstracts are summarized:

Poster M17: Patient preference of third line therapy for overactive bladder

Poster M18: Determining patient preferences in the treatment of medication-refractory overactive bladder

Poster M12: Trends in overactive bladder therapy utilization: an evaluation of the impact of clinical care pathways and practice guidelines

Poster M11: Use of neuromodulation and chemodenervation for overactive bladder among FPMRS-certified urologists

Clinical Science Abstract 11: Change in practice patterns following female urology subspecialization: an analysis of case logs among certifying urologists

Poster M10: Fixed – life vs. rechargeable sacral neuromodulation (SNM): patient choice and device specific satisfaction

Poster NM108: Slower than anticipated adoption of the InterStim Micro

Clinical Science Abstract 21: InterStim Micro improves quality of life in overactive bladder subjects at 3- month follow up in a global, prospective, post-market study

Poster NM109: History of sacral neuromodulation in urology

Poster NM115: Simple anchor technique prevents migration of sacral neuromodulation test leads

Clinical Science Abstract 18: Treatment of urinary urgency incontinence (UUI) with an ultra-miniaturized sacral nerve modulation (SNM) system: outcomes of the SANS-UUI feasibility study

Poster OM40: Does success with posterior tibial nerve stimulation predict conversion to sacral neuromodulation?

Poster OM38: Oasis pivotal trial to evaluate the safety and efficacy of the Renova iStim system for the treatment of women with OAB

Poster OM37: OAB patient reported outcome improvements after 12 weeks of using a wearable surgery free, closed-loop bladder modulation system in a home setting - a feasibility trial

Poster NM114: A closed-loop, surgery-free wearable bladder modulation system with objective confirmation of nerve activation is easy to use and can improve OAB symptoms in 12 weeks

Clinical Science Abstract 8: Noninvasive spinal neuromodulation improves symptoms in patients with neurogenic bladder after stroke

Clinical Science Abstract 24: Noninvasive spinal neuromodulation mitigates symptoms of overactive bladder

Related Videos
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Woman talking with doctor | Image Credit: © rocketclips - stock.adobe.com
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Gamal M. Ghoniem, MD, FACS, ABU/FPMRS, gives an answer during a video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Zhina Sadeghi, MD, answers a question during a video interview
Stephanie Gleicher, MD, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.